Singular Genomics Systems Inc (OMIC) Total Business Assets

Public company logo of Singular Genomics Systems, Inc. (OMIC)

The price evolution of Singular Genomics Systems (OMIC), whose total assets reach 235.53, is based on the consolidation of production capacities and laboratories in California to ensure output quality. Demand for genome analysis systems is moderately volatile, as equipment procurement is often tied to the volume of government subsidies. Meanwhile, plants operate on schedule, regularly updating lithography equipment in sterile chip fabrication cleanrooms.

Singular Genomics Systems (OMIC) Company Total Assets: for the period 07/04/2022 - 03/01/2025

Singular Genomics Systems Inc - analytical breakdowns and key metrics (OMIC)

- price and consensus price forecast:
Stock Quotes singulargenomics.com|OMIC - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization Singular Genomics Corp|OMIC - Total Company Value
- book capitalization data:
Equity per Share Singular Genomics|OMIC - Book Capitalization|Market Capitalization to Book Value Ratio singulargenomics.com|OMIC - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Capital Coefficient Singular Genomics Systems|OMIC - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Singular Genomics Corp|OMIC - Company Debts|Debt to Book Value Ratio Singular Genomics Corp
Comprehensive company analysis:Singular Genomics Systems
Manufactured product of Singular Genomics Systems

Assessing the financial stability of Singular Genomics Systems requires an analysis of the aggregate resources supporting the development of energy-efficient, sustainable genomic technologies. This indicator, reverse-calculated via ROA, combines equity and liabilities, allowing consolidated asset trends to determine the balance between scaling the production base and capital management efficiency to minimize investment risks.

Who Singular Genomics Systems competes with

Tempus AI, Inc (TEM) - Cumulative Company Assets|Company Total Assets Qiagen (QGEN)|Total Business Assets IONS|Aggregate Company Assets Repligen Corp. RGEN|Total Business Assets Avidity Corp (RNA)|Company Total Assets CRSP (CRISPR Therapeutics AG)|genedx.com - Company Total Assets|Aggregate Company Assets RARE (Ultragenyx)|BEAM - Company Total Asset Base|Sarepta Therapeutics Inc - Company Total Assets|TWST (Twist Bioscience Corp) - Company Total Asset Base|Aggregate Company Assets 10x Genomics, Inc. (TXG)|Total Business Assets intelliatx.com|STOK: Company Total Assets|Company Balance Sheet Assets BioLife Solutions Inc BLFS|Cumulative Company Assets WVE (Wave Life Sciences Corp)|Maze Therapeutics Corp - Company Total Assets|SION - Aggregate Company Assets|PRME - Aggregate Company Assets|TSHA: Company Total Assets|QURE (uniQure NV) - Company Total Assets|MGTX - Aggregate Company Assets|Aggregate Asset Value REGENXBIO Corp (RGNX)|Solid Biosciences Inc. (SLDB) - Cumulative Company Assets|Aggregate Asset Value ocugen.com (OCGN)|PACB (PacBio) - Company Total Assets|Company Balance Sheet Assets Benitec Biopharma Inc BNTC|DSGN (Design Pharma) - Company Total Assets|RCKT: Company Assets|Aggregate Company Assets 4D Molecular Therapeutics|LXEO (Lexeo Therapeutics, Inc.) - Total Business Assets|Aggregate Company Assets KRRO (Korro Bio Inc.)|Company Assets EDIT|Aggregate Company Assets SLN (Silence Therapeutics Inc.)|Cumulative Company Assets proqr.com (PRQR)|Company Total Assets CDXS|Company Total Asset Base sangamo.com SGMO|NAUT: Company Total Assets|MGX: Cumulative Company Assets|Precision BioSciences, Inc. - Aggregate Company Assets|Company Total Asset Base Generation Bio|BOLD - Cumulative Company Assets|Aggregate Asset Value XCUR|IMNN (Imunon, Inc.) - Aggregate Company Assets|Company Total Asset Base phiopharma.com PHIO|MBIO: Cumulative Company Assets|TransCode Therapeutics Inc. - Company Assets|Aggregate Company Assets BNGO (Bionano)|adnas.com (APDN) - Company Total Asset Base|BLUE - Cumulative Company Assets|ImmunoPrecise Antibodies Ltd. (IPA) - Aggregate Business Assets|Company Total Assets OMGA (Omega)|Company Assets RGLS|Aggregate Company Assets SYRS (Syros Pharmaceuticals)|Cumulative Company Assets TBIO (telesisbio.com)|Aggregate Company Assets TCON|Unity Biotechnology Inc. - Company Total Asset Base